Recent advances in the genetics of dementia with Lewy bodies

Current Neurology and Neuroscience Reports

Volumn 8, Issue 3, 2008, Pages 187-189

  Bonifati, Vincenzo ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; GLUCOSYLCERAMIDASE; LEUCINE RICH REPEAT KINASE 2; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

CHROMOSOME 2Q; CHROMOSOME MAP; DEMENTIA; DIFFUSE LEWY BODY DISEASE; GENE LOCUS; GENE MUTATION; GENETIC CODE; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; HUMAN; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NEUROPATHOLOGY; PARKINSON DISEASE; REVIEW; GENETICS; MUTATION;

ALPHA-SYNUCLEIN; GLUCOSYLCERAMIDASE; HUMANS; LEWY BODY DISEASE; MUTATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 49649093693     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-008-0030-1     Document Type: Review

References (30)

1. Lippa CF, Duda JE, Grossman M, et al.: DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007, 68:812-819.
2. McKeith IG: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzbeimers Dis 2006, 9:417-423.
3. Geser F, Wenning GK, Poewe W, McKeith I: How to diagnose dementia with Lewy bodies: state of the art. Mov Disord 2005, 20(Suppl 12):S11-S20.
4. Lippa CF, Fujiwara H, Mann DM, et al.: Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998, 153:1365-1370.
5. Leverenz A Fishel MA, Peskind ER, et al.: Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol 2006, 63:370-376.
6. Ishikawa A, Piao YS, Miyashita A, et al.: A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease. Ann Neurol 2005, 57:429-434.
7. Harding AJ, Das A, Kril JJ, et al.: Identification of families with cortical Lewy body disease. Am J Med Genet B Neuropsychiatr Genet 2004, 128:118-122.
8. Tsuang DW, DiGiacomo L, Bird TD: Familial occurrence of dementia with Lewy bodies. Am J Geriatr Psychiatry 2004, 12:179-188.
9. Yamaguchi K, Cochran EJ, Murrell JR, et al.: Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T muiption in the alpha-synuclein gene. Acta Neuropathol 2005, 110:298-305.
10. Morfis L, Cordato DJ: Dementia with Lewy bodies in an elderly Greek male due to alpha-synuclein gene mutation. J Clin Neurosci 2006, 13:942-944.
11. Zarranz JJ, Alegre J, Gomez-Esteban JC, et al.: The new mutation, E46K, of alpha-synuclein causes parkinson and Lewy body dementia. Ann Neurol 2004, 55:164-173.
12. Singleton A B, Farrer M, Johnson J, et al.: α-Synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
13. Fuchs J, Nilsson C, Kachergus J, et al.: Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 2007, 68:916-922.
14. Ibanez P, Bonnet AM, Debarges B, et al.: Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 2004, 364:1169-1171.
15. Chartier-Harlin MC, Kachergus J, Roumier C, et al.: Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004, 364:1167-1169.
16. Kruger R, Kuhn W, Leenders KL, et al.: Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers. Neurology 2001, 56:1355-1362.
17. Golbe LI, Di Iorio G, Sanges G, et al.: Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 1996, 40:767-775.
18. Hashimoto M, Rockenstein E, Mante M, et al.: β-Synuclein inhibits α-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron 2001, 32:213-323.
19. Ohtake H, Limprasert P, Fan Y, et al.: Beta-synuclein gene alterations in dementia with Lewy bodies. Neurology 2004, 63:805-811.
20. Wei J, Fujita M, Nakai M, et al.: Enhanced lysosomal pathology caused by beta-synudein mutants linked to dementia with Lewy bodies. J Biol Chem 2007, 282:28904-28914
21. Paisan-Ruiz C, Jain S, Evans EW, et al.: Cloning of the gene containing mutations that cause PARK84-linked Parkinson's disease. Neuron 2004, 44:595-600.
22. Zimprich A, Biskup S, Leitner P, et al.: Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.
23. Bonifati V: LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease. Neurocbem Res 2007, 32:1700-1708.
24. Ross OA, Toft M, Whittle AJ, et al.: Lrrk2 and Lewy body disease. Ann Neurol 2006, 59:388-393.
25. Haubenberger D, Bonelli S, Hotzy C, et al.: A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease. Mov Disord 2007, 22:1640-1643.
26. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R: Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 2004, 351:1972-1977.
27. Clark LN, Ross BM, Wang Y, et al.: Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology 2007, 69:1270-1277.
28. Goker-Alpan O, Giasson BI, Eblan MJ, et al.: Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology 2006, 67:908-910.
29. Bogaerts V, Engelborghs S, Kumar-Singh S, et al.: A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. Brain 2007, 130:2277-2291. Linkage analysis in a large Belgian family led to the mapping of a
30. Pankratz N, Nichols WC, Uniacke SK, et al.: Significant linkage of Parkinson disease to chromosome 2q36-37. Am J Hum Genet 2003, 72:1053-1057.